Corpus Intelligence IC Memo — PRINCETON COMMUNITY HOSPITAL 2026-04-26 03:45 UTC
IC Memo — PRINCETON COMMUNITY HOSPITAL
Investment Committee Memorandum | WV | 115 beds | Grade B | EBITDA uplift $21.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PRINCETON COMMUNITY HOSPITAL

CCN 510046 | MERCER, WV | 115 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

PRINCETON COMMUNITY HOSPITAL is a 115-bed suburban community hospital in MERCER, WV with $290.2M in net patient revenue and a 12.8% operating margin. The hospital serves a payer mix of 32.2% Medicare, 8.9% Medicaid, and 58.9% commercial.

Thesis: Turnaround. Our ML models identify $21.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 12.8% to 20.2% (+736bps).

Net Revenue HCRIS$290.2M
Current EBITDA COMPUTED$37.1M
Operating Margin COMPUTED12.8%
Occupancy HCRIS84.9%
Revenue / Bed COMPUTED$2.5M
Net-to-Gross HCRIS35.1%
Distress Probability ML40.2%

2. Market Context & Competitive Position

62
WV Hospitals
-0.3%
State Median Margin
18
Comparable Hospitals

WV has 62 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 12.8% places it above the state median. Among 18 size-comparable peers (58-230 beds), the median margin is 3.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (58-230), prioritizing same-state peers. 18 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PRINCETON COMMUNITY HOSPITAL (Target)WV115$290.2M12.8%
WHEELING HOSPITALWV189$411.4M-8.5%
CITY HOSPITAL INC.WV163$304.2M-2.8%
THOMAS MEMORIAL HOSPITALWV176$209.0M26.7%
WEIRTON MEDICAL CENTERWV127$182.4M9.4%
MONONGALIA GENERAL HOSPITALWV160$155.1M-5.3%
REYNOLDS MEMORIAL HOSPITALWV94$123.6M3.8%
BECKLEY ARHWV72$109.2M-37.8%
LOGAN REGIONAL MEDICAL CENTERWV132$104.0M3.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $21.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$6.1M+210bp18mo
Cost to Collect4.5%2.5%$5.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$5.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.5M+122bp9mo
Clean Claim Rate88.0%96.0%$186K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$6.1M
Cost to Collect
$5.8M
Denial Rate Reduction
$5.7M
A/R Days Reduction
$3.5M
Clean Claim Rate
$186K
Total EBITDA Uplift$21.4M
Current EBITDA$37.1M
+ RCM Uplift+$21.4M
Pro Forma EBITDA$58.5M
Current Margin12.8%
Pro Forma Margin20.2%
WC Released (1x)$11.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$57.1M$458.6M8.03x51.7%
Base (11x exit)10.0x11.0x$57.1M$523.0M9.15x55.7%
Bull Case9.0x11.0x$51.4M$612.1M11.90x64.1%
Bull (12x exit)9.0x12.0x$51.4M$682.9M13.28x67.7%
Bear Case11.0x10.0x$62.8M$333.2M5.30x39.6%
Bear (11x exit)11.0x11.0x$62.8M$387.0M6.16x43.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 18 hospitals with 58-230 beds
  • Same-state prioritization (n=19)
  • Comp margins: P25=-8.5% / P50=3.4% / P75=12.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.